Back to the free edition

Paid edition · Amazon Kindle + paperback

State of Nootropics 2026: Full Edition

The annual report at full depth. 12 chapters, ~18,000 words. The free edition’s 8 chapters plus 4 additional: substance deep dives, protocol design, self-tracking methodology, and the five-year forward look.

Kindle ebook

$9.99

Reflowable EPUB. Available on every Kindle device, the Kindle app on iOS / Android / desktop, and Kindle Unlimited.

Buy on Amazon

Paperback

$14.99

6×9 in., single-column, printed on demand via Amazon KDP. Ships globally.

Buy paperback

Amazon links carry our Associates tag (nootropics.com-20), purchases support the editorial work that produced this report.

What’s in the full edition

All 8 chapters of the free public edition, covering the state of the field, the substances people actually take, stack patterns, sleep, the longevity-cognition convergence, the grey market, AI advisor patterns, and what we got wrong in 2025, plus the four full-edition chapters below:

  • Chapter 9, Substance deep dives

    Eight substances treated at the depth a structured reference entry can't accommodate. Caffeine, L-Theanine, Modafinil, Lion's Mane, Bacopa, Creatine, Ashwagandha, and NR, each with the mechanism, the 2026 evidence picture, the honest read of where marketing has overshot, and a five-year forecast.

  • Chapter 10, Protocol design 101

    The principles that separate a designed protocol from an accumulated stack. Choosing one goal, matching protocol to goal, the one-substance-at-a-time discipline, dose titration, cycling, defining failure criteria in advance, and the quarterly subtraction review.

  • Chapter 11, Tracking your own response

    The four-metric daily tracking method that produces interpretable self-experimentation data. What to track, when, how to look at the data, and what to honestly expect from the analysis.

  • Chapter 12, The next five years

    Three forecasts. Continued regulatory tightening on supplement-channel availability. The longevity-cognition merge producing its first widely-validated compound. AI-driven personalized protocol design becoming the dominant consumer interface, with explicit comment on what we will and won't build into our own tools.

Why pay for this

The free edition exists because the field needed a non-vendor, non-influencer, well-sourced annual synthesis. The full edition exists because the report’s editorial work, the substance research, the protocol design discipline, the tracking methodology, takes thousands of hours per year and the affiliate-and-advertising business model alone does not support it.

Paying for the full edition is the most direct way to support the work that produces both editions. It also gets you a real book, substance-level depth across the eight deep-dive subjects, the protocol design chapter that condenses years of editorial practice into one workable framework, and the tracking methodology chapter that has, in our experience, been the highest-leverage single piece of advice in personal cognitive enhancement.

  • All 12 chapters, ~18,000 words
  • Substance-by-substance deep dives on 8 foundation compounds
  • Protocol design framework + 4-metric tracking methodology
  • Forward look at regulatory, longevity-cognition, and AI-driven personalization
  • Available in Kindle reflowable + 6×9 paperback
  • Free upgrades to errata across the year; 2027 edition sold separately

Prefer the free edition?

The 8-chapter free public edition is at nootropics.com/state-of-nootropics-2026. CC BY 4.0, share, cite, quote freely.

Go to the free edition

The State of Nootropics 2026 Full Edition is an editorial publication. The substances and protocols discussed are not medical advice. Individual response varies; pregnancy, lactation, prescription medications, and pre-existing conditions all change the calculus. Coordinate any new protocol with a qualified clinician. See our full disclaimer and terms.